NCT02828878View on ClinicalTrials.gov

Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
Hematological Malignancies
Interventions
BIOLOGICAL

Allogeneic MPBC transplantation from matched related donor

Trial Locations (2)

Unknown

RECRUITING

Rambam Health Care Campus, Haifa

RECRUITING

Hadassah Medical Center, Ein Kerem, Jerusalem, Jerusalem

Sponsors
All Listed Sponsors
lead

Cellect Biotechnology

INDUSTRY